BSE: 544272
SHIV TEXCHEM LIMITED
Imports and distributes hydrocarbon-based chemicals to industrial customers in paints, agro-chemicals, pharmaceuticals, and printing inks, with storage facilities at 5 major Indian ports. The business is shifting toward higher-margin specialty products such as Mixed Heptane, which the company states carries a 25% gross margin. Recent disclosed orders include Rs 15 Cr from BASF India and Rs 11 Cr from GNFC. In FY26, total income reached Rs 2,78,209 lakhs (up 26.2% from Rs 2,20,480 lakhs in FY25), with profit after tax at Rs 7,782 lakhs versus Rs 4,811 lakhs the year before. Operating cash flow was deeply negative at Rs -32,716 lakhs, driven by inventory build-up of Rs 15,852 lakhs and trade receivable increases of Rs 11,689 lakhs, while total borrowings climbed to Rs 70,053 lakhs. The company was placed on the OFAC sanctions list in October 2025, restricting U.S.-linked banking channels, with management stating business operations remain uninterrupted. Listed on BSE SME platform (scrip code 544272) since 2024. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Chemical trading and distribution. Asset-light chemical trading and distribution
Exhibit 1: Financial summary, FY25–FY26 (all audited; no estimate years)
| ₹ crore · standalone | FY25 | FY26 |
|---|---|---|
| Revenue | 2,202 | 2,776 |
| EBITDA (ex other income) | — | — |
| margin % | — | — |
| Owners' profit | — | — |
| EPS, as reported (₹) | 30.67 | 49.61 |
| ROE % · ROCE % | — · 20.8 | — · 21.4 |
| Debt / equity (x) | — | — |
| Cash from operations | (116) | (327) |
| Capex | (0) | (0) |
Exhibit 2: Quarterly performance, last 4 quarters
| ₹ crore | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|
| Revenue | 1,031 | 1,171 | 1,503 | 1,273 |
| Profit before tax | 28 | 38 | 58 | 49 |
| Net profit | — | — | — | — |
| EPS (₹) | 12.09 | 18.58 | 27.38 | 22.23 |
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UNIPHOS ENTERPRISES LTD | 607 | 30.0 | 0.25 | — | 0.8 | 0.8 | — | — |
| VINYL CHEMICALS (I) LTD. | 481 | 20.7 | 3.69 | — | 12.7 | 16.8 | — | 9.0 |
| EVEXIA LIFECARE LIMITED | 310 | 55.0 | 0.71 | 108.2 | 0.4 | 0.3 | 0.7 | 3.3 |
| BHAVIK ENTERPRISES LIMITED | 303 | 20.5 | — | — | — | 11.1 | — | — |
| SHANKAR LAL RAMPAL LTD | 243 | 13.2 | 1.98 | — | 11.0 | 14.7 | — | 9.4 |
| A-1 LIMITED | 236 | 21.4 | 4.36 | 22.0 | 11.1 | 14.8 | — | 3.5 |
| MYSORE PETRO CHEMICALS L | 75 | 46.9 | 0.33 | 80.5 | 0.4 | 0.2 | 18.0 | (0.4) |
| Yash Chemex Limited | 51 | 25.1 | 0.83 | 13.9 | 4.0 | 5.2 | 20.6 | (0.0) |
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 1.3 | 20.6 | 1 of 12 | 100% |
| ROCE | 16.1 | 3.0 | 2 of 14 | 92% |
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 12 Oct 2026 · Reg 74(5) Filing: All Shares Already in Demat Form | compliance | minimal | — | — |
| 30 Sept 2026 · AGM 2026: All 4 resolutions passed with 100% shareholder approval | compliance | minimal | — | — |
| 28 Sept 2026 · AGM approves director appointments at Shiv Texchem | board shareholder meetings | medium | — | — |
| 28 Sept 2026 · Gist of Proceedings of the 21st Annual General Meeting of Shiv Texchem Limited held today, i.e. 28th September, 2026. | board shareholder meetings | low | — | — |
| 26 Sept 2026 · Trading window closed from Oct 1 for half-year results | compliance | minimal | — | — |
| 27 Aug 2026 · FY26 Annual Report: revenue up 26%, PAT up 62%, no dividend | results | high | — | — |
| 27 Aug 2026 · Shiv Texchem 21st AGM on Sep 28, 2026 via video conferencing | board shareholder meetings | low | — | — |
| 22 Aug 2026 · Internal Auditor Resigns Mid-Term at Shiv Texchem | management changes | medium | — | — |
| 22 Aug 2026 · Internal Auditor Appointed for FY 2026-27 | management changes | low | — | — |
| 22 Aug 2026 · Board approves independent director regularisation and internal auditor appointment | management changes | medium | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.